Vera Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
8000 Marina Blvd Ste 120, Brisbane, Cali...Phone Number
(650) 770-0077Website
www.veratx.comRevenue
$134.2 MillionStock Symbol
VERAIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
6
5
1
1
1
1
About Vera Therapeutics
Vera Therapeutics is a clinical-stage biotechnology company focused on developing treatments for immunological diseases that improve patients' lives. Vera's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. In addition, Vera is evaluating additional diseases where the reduction of autoantibodies by atacicept may prove medically useful, including lupus nephritis, a severe renal manifestation of systemic lupus erythematosus.Explore more
Vera Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vera Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Vera Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Vera Therapeutics recently announced quarterly report
Click to see if Vera Therapeutics had a recent Job posting/layoffs
Vera Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Vera Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Vera Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Vera Therapeutics has new funding data
Product Launch: Get notified when Vera Therapeutics launches new products
Recommended Actions
Reach out to Masked Content who joined Vera Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Vera Therapeutics
Compare insights from companies similar to Vera Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vera Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vera Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vera Therapeutics.
Vera Therapeutics financials insights
Gather financial insights about Vera Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series B
$17M
2021
Series C
$80M
Vera Therapeutics Tech Stack
A closer look at the technologies used by Vera Therapeutics
Most Recent Scoops
Person-Based
Pharmaceuticals
Person-Based
Product Development, Pharmaceuticals
Person-Based
Earnings, Financial Reporting, Finance
Person-Based
Events
Open Position
Vera Therapeutics News & Media
Vera Therapeutics Announces Alignment with U.S. FDA on Earlier ORIGIN Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults with IgA Nephropathy
Vera Therapeutics Announces Alignment with U.S. FDA on Earlier ORIGIN Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults with IgANInvestment Firm Closes Out Entire $18.1 Million Position in Biotech Stock, According to Latest SEC Filing
This biotech focuses on biologic therapies for immunological diseases, with lead candidates in nephrology and infectious disease.Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vera Therapeutics
Sign Up For FreeTo access detailed company insights
Vera Therapeutics is a clinical-stage biotechnology company focused on developing treatments for immunological diseases that improve patients' lives. Vera's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator (BLyS) and a proliferation-inducing liga... Read More
